• Subrahmanyam CH
• V. Bhavatarini
• B.V.Sandeep
• KPJ Hemalatha
• S.Rama Krishna

Over the past few decades, enhanced understanding of complex disease biology has unraveled plethora of novel targets for drug discovery. With an increasing focus of delivering targeted thera-pies, drug development companies have adapted a wider chemical toolbox for strategic drug de-sign and clinical success. In this article, we highlight the current and new chemical modalities considered for drug discovery including: small molecules, antibody-drug conjugates, RNA-based therapies, protein degraders, and gene therapy.

Drug Modalities, Small Molecules, Antibodies, RNA-based therapy, PROTACs, Gene Therapy

"Current and Emerging Therapeutic Modalities in Drug Development", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 6, page no.c497-c502, June-2021, Available :http://www.jetir.org/papers/JETIR2106339.pdf

"Current and Emerging Therapeutic Modalities in Drug Development", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 6, page no. ppc497-c502, June-2021, Available at : http://www.jetir.org/papers/JETIR2106339.pdf